259 related articles for article (PubMed ID: 3080285)
1. A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects.
Lanza FL
Dig Dis Sci; 1986 Feb; 31(2 Suppl):131S-136S. PubMed ID: 3080285
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum.
Lanza FL; Aspinall RL; Swabb EA; Davis RE; Rack MF; Rubin A
Gastroenterology; 1988 Aug; 95(2):289-94. PubMed ID: 3134266
[TBL] [Abstract][Full Text] [Related]
3. [Prophylactic effect of Misoprostol on gastric lesions induced by aspirin (ASA) in healthy subjects].
Naves J; Santoyo R; Morales I
Rev Gastroenterol Mex; 1989; 54(4):203-6. PubMed ID: 2515571
[TBL] [Abstract][Full Text] [Related]
4. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic efficacy of misoprostol in peptic ulcer disease.
Watkinson G; Hopkins A; Akbar FA
Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
[TBL] [Abstract][Full Text] [Related]
6. Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study.
Silverstein FE; Kimmey MB; Saunders DR; Levine DS
Dig Dis Sci; 1986 Feb; 31(2 Suppl):137S-141S. PubMed ID: 3080286
[TBL] [Abstract][Full Text] [Related]
7. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms.
Lanza FL; Fakouhi D; Rubin A; Davis RE; Rack MF; Nissen C; Geis S
Am J Gastroenterol; 1989 Jun; 84(6):633-6. PubMed ID: 2499187
[TBL] [Abstract][Full Text] [Related]
8. Misoprostol versus cimetidine in tolmetin-induced mucosal injury.
Wallin BA; Frank WO; Young MD
Gastroenterology; 1989 May; 96(5 Pt 1):1374-6. PubMed ID: 2495235
[No Abstract] [Full Text] [Related]
9. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin-stimulated recovery of the human duodenal epithelium: effects of misoprostol on ethanol damage.
Foschi D; Marazzi M; Toti GL; Radaelli E; Ferrante F; Vaiani G; Galeone M; Trabucchi E
Am J Gastroenterol; 1990 Nov; 85(11):1498-502. PubMed ID: 2122722
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview.
Dajani EZ; Nissen CH
Dig Dis Sci; 1985 Nov; 30(11 Suppl):194S-200S. PubMed ID: 3932054
[TBL] [Abstract][Full Text] [Related]
12. Cytoprotection by a synthetic prostaglandin against ethanol-induced gastric mucosal damage. A double-blind endoscopic study in human subjects.
Agrawal NM; Godiwala T; Arimura A; Dajani EZ
Gastrointest Endosc; 1986 Apr; 32(2):67-70. PubMed ID: 3086177
[TBL] [Abstract][Full Text] [Related]
13. Protection by misoprostol against naproxen-induced gastric mucosal damage.
Aadland E; Fausa O; Vatn M; Cohen H; Quinlan D
Am J Med; 1987 Jul; 83(1A):37-40. PubMed ID: 3113244
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
Lanza FL; Kochman RL; Geis GS; Rack EM; Deysach LG
Am J Gastroenterol; 1991 Dec; 86(12):1743-8. PubMed ID: 1962619
[TBL] [Abstract][Full Text] [Related]
15. Protection of the gastroduodenal mucosa from the effects of diclofenac sodium: role of highly selective vagotomy and misoprostol.
Giannoukas AD; Baltoyiannis G; Milonakis M; Nastos D; Papagikos L; Kappas AM; Fatouros M; Papadimitriou C; Cassioumis D
World J Surg; 1996 May; 20(4):501-5 discussion 505-6. PubMed ID: 8662142
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic assessment of the effects of dipyrone (metamizol) in comparison to paracetamol and placebo on the gastric and duodenal mucosa of healthy adult volunteers.
Bianchi Porro G; Ardizzone S; Petrillo M; Caruso I; Montrone F
Digestion; 1996; 57(3):186-90. PubMed ID: 8739093
[TBL] [Abstract][Full Text] [Related]
17. Overview of the mucosal protective effects of misoprostol in man.
Dajani EZ
Prostaglandins; 1987; 33 Suppl():117-29. PubMed ID: 3122272
[TBL] [Abstract][Full Text] [Related]
18. Effects of alendronate on gastric and duodenal mucosa.
Lanza F; Rack MF; Simon TJ; Lombardi A; Reyes R; Suryawanshi S
Am J Gastroenterol; 1998 May; 93(5):753-7. PubMed ID: 9625122
[TBL] [Abstract][Full Text] [Related]
19. Protective effects against alcohol insult: does somatostatin play any role?
Agrawal NM; Godiwala T; Arimura A; Groot K; Dajani E
Postgrad Med J; 1988; 64 Suppl 1():15-20. PubMed ID: 2901743
[TBL] [Abstract][Full Text] [Related]
20. Gastric protection by misoprostol against 1,300 mg of aspirin. An endoscopic dose-response study.
Silverstein FE; Kimmey MB; Saunders DR; Surawicz CM; Willson RA; Silverman BA
Am J Med; 1987 Jul; 83(1A):32-6. PubMed ID: 3113243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
